Summary DocuSign shares, despite a recovery in the last month, have seen one of the greater valuation compressions in IT space over the course of the late valuation correction. The shares are now valued at about typical levels for the company’s growth rate and cash flow generation. The company has expanded far beyond its e-sign…
Cognizant (CTSH) We are buying 200 shares of Cognizant (CTSH) in our income/stability portfolio, using up our cash balance, and a little more. We are buying the shares at a price of $64.63, the closing price on Monday, which will take $12,926. We had sold Cognizant shares back in August at $75/share in the wake…
This evening, in the wake of a strong quarterly report, DocuSign announced 2 separate transactions. In one transaction, the company announced that the underwriters were offering an additional 8 million shares of stock by selling stockholders, with an additional 1.2 million shares available for sale as part of the transaction. The shares are being sold…
As I mentioned yesterday, this is a multi-day stretch of multiple earnings releases. I will get to most of them over time-a couple in each post. But if any subscriber wants a quick response on a particular earnings release, I am happy to oblige. Simply send a query and I will respond about the earnings…
SHOP SHOP reported its results yesterday morning. Unfortunately, the transcript of its call was delayed and never made it to SA. This has delayed this post. I am not sure how much of a problem that is for subscribers, but I never like to comment about earnings without reading a call to ensure I get…
Summary DocuSign recently conjoyed a well received IPO in which it raised more than $500 million. The shares, in the wake of a quarter that was well above expectations in terms of revenue growth, bookings and margins, have appreciated by about 80% from the IPO price. The company has provided what appears to be very…